Activated prothrombin complex concentrate for reversal of oral factor Xa inhibitors at a level 1 trauma center

被引：1
|
作者：
Bobby, Lauren [1 ]
Westlake, Evan [1 ]
Esplin, Nathan [2 ]
Young, Sarah [1 ]
机构：
[1] Allegheny Gen Hosp, Dept Pharm, 320 North Ave, Pittsburgh, PA 15212 USA
[2] Allegheny Gen Hosp, Dept Neurosurg, 320 North Ave, Pittsburgh, PA 15212 USA
来源：
THROMBOSIS RESEARCH | 2021年 / 206卷
关键词：
Apixaban; Rivaroxaban; Reversal; Activated prothrombin complex concentrate (aPCC); Intracranial hemorrhage (ICH); Andexanet alfa; ANTICOAGULANTS; MANAGEMENT; OUTCOMES; FEIBA;
D O I：
10.1016/j.thromres.2021.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：33 / 35
页数：3
相关论文
共 50 条
  • [1] Emergent reversal of oral factor Xa inhibitors with four-factor prothrombin complex concentrate
    Lipari, Louis
    Yang, Sam
    Milligan, Brian
    Blunck, Joseph
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (12) : 2641 - 2645
  • [2] 3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
    Hays, William Blake
    Billups, Kelsey
    Nicholson, Jessica
    Bailey, Abby M.
    Gregory, Haili
    Weeda, Erin R.
    Weant, Kyle A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2025, 58 (02) : 276 - 283
  • [3] Outcomes of activated prothrombin complex concentrate for direct Xa inhibitor bleeding
    Smythe, Maureen A.
    Koerber, John M.
    Hoffman, Janet L.
    Mertz, Sean
    Fritsch, Karissa
    Chehab, Fatme
    Baalbaki, Nour
    Krishnan, Anant
    THROMBOSIS RESEARCH, 2021, 206 : 142 - 144
  • [4] Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter study
    Estroff, Jordan M.
    Devlin, Joseph
    Hoteit, Lara
    Hassoune, Adnan
    Neal, Matthew D.
    Brown, Joshua B.
    Lu, Liling
    Kotch, Shannon
    Hazelton, Joshua P.
    Christian, Ashton B.
    Yeates, Eric O.
    Nahmias, Jeffry
    Jacobson, Lewis E.
    Williams, Jamie
    Schuster, Kevin M.
    O'Connor, Rick
    Semon, Gregory R.
    Straughn, Angela D.
    Cullinane, Daniel
    Egodage, Tanya
    Kincaid, Michelle
    Rollins, Allison
    Amdur, Richard
    Sarani, Babak
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2024, 97 (04) : 541 - 545
  • [5] The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
    Schultz, Nina Haagenrud
    Hoa Thi Tuyet Tran
    Bjornsen, Stine
    Henriksson, Carola Elisabeth
    Sandset, Per Morten
    Holme, Pal Andre
    THROMBOSIS JOURNAL, 2017, 15
  • [6] Four-factor prothrombin complex concentrate for the reversal of factor Xa inhibitors for traumatic intracranial hemorrhage
    Dybdahl, Daniel
    Walliser, Grant
    Spalding, M. Chance
    Pershing, Michelle
    Kincaid, Michelle
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2019, 37 (10) : 1907 - 1911
  • [7] Utilization of 4-Factor Prothrombin Complex Concentrate for Reversal of Oral Factor Xa Inhibitor-Associated Acute Major Bleeding: A Case Series
    Reynolds, Tessa R.
    Gilbert, Brian W.
    Hall, Katherine M.
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (05) : 755 - 760
  • [8] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Ammar, Abdalla A.
    Ammar, Mahmoud A.
    Owusu, Kent A.
    Brown, Stacy C.
    Kaddouh, Firas
    Elsamadicy, Aladine A.
    Acosta, Julian N.
    Falcone, Guido J.
    NEUROCRITICAL CARE, 2021, 35 (01) : 255 - 261
  • [9] Outcomes Associated With 4-Factor Prothrombin Complex Concentrate Administration to Reverse Oral Factor Xa Inhibitors in Bleeding Patients
    Highsmith, Emily A.
    Morton, Celia
    Varnado, Sara
    Donahue, Kevin R.
    Sulhan, Suraj
    Lista, Annette
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (05) : 598 - 605
  • [10] Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors
    Schulman, Sam
    Bhagirath, Vinai
    Chan, Noel
    Germini, Federico
    Ikesaka, Rick
    Iorio, Alfonso
    Mithoowani, Siraj
    Weitz, Jeff I.
    Gross, Peter L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (10) : 2761 - 2766
12345